The Europe fish vaccines market was valued at US$ 110.00 million in 2022 and is expected to reach US$ 191.33 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.
Based on vaccine type, the Europe fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.
Based on application, the Europe fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.
Based on route of administration, the Europe fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.
Based on species, the Europe fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.
Based on country, the Europe fish vaccines market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe fish vaccines market share in 2022.
Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the Europe fish vaccines market.
Surging Demand for Aquatic Animal-Derived Food Products Fuel the Europe Fish Vaccines Market
An unhealthy diet is a growing concern in developing and developed countries, resulting in a variety of negative health consequences. Thus, fish is highly advisable in diet for healthy growth and development as it is rich in vitamins, minerals, lipids, and macronutrients such as proteins. Additionally, it is believed that aquaculture is the most effective way to produce high-quality proteins for a sustainable human diet. Growing awareness regarding the nutritional benefits of fish consumption propels the demand for sustainable, high-quality, and healthy meat products. Therefore, the rising consumption of fish and fish-derived products fuels the fish vaccines market growth.Europe Fish Vaccines Market Overview
The European fish vaccines market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the fish vaccines market. The European fish vaccines market is expected to witness significant growth during the forecast period due to factors such as the significant growth in aquaculture industry, surging demand for aquatic animal-derived food products, growing research and development activities for fish vaccines development by market players in the region. Aquaculture is one of the key food-production sectors in the UK. According to the Department of Business and Trade (UK), seafood purchase is estimated to be ~US$ 5.14 billion in Great Britain. According to Innovate UK, the production value of the aquaculture industry in the UK is ~US$ 730.88 annually. Various events are organized by regulatory authorities to increase the awareness regarding the importance of maintaining aquaculture and fisheries. In May 2023, the UK's largest trade show-Aquaculture UK-for the community of aquaculture was held in Aviemore, Scotland. This trade show focused on innovation and sustainability in fish health, cleaner fish breeding, genetic selection, and other topics.Europe Fish Vaccines Market Segmentation
The Europe fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.Based on vaccine type, the Europe fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.
Based on application, the Europe fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.
Based on route of administration, the Europe fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.
Based on species, the Europe fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.
Based on country, the Europe fish vaccines market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe fish vaccines market share in 2022.
Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the Europe fish vaccines market.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Europe Fish Vaccine Market - Key Industry Dynamics
5. Fish Vaccine Market - Europe Market Analysis
6. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type
7. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Application
8. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration
9. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Species
10. Europe Fish Vaccine Market - Country Analysis
11. Fish Vaccine Market - Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
- Elanco Animal Health Inc
- Hipra SA
- Merck & Co Inc.
- Phibro Animal Health Corp
- Vaxxinova International BV
- Zoetis Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 88 |
| Published | February 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 110 Million |
| Forecasted Market Value by 2030 | 191.33 Million |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 6 |
